BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Bansal S, Burman A, Tripathi AK. Advanced glycation end products: Key mediator and therapeutic target of cardiovascular complications in diabetes. World J Diabetes 2023; 14(8): 1146-1162 [PMID: 37664478 DOI: 10.4239/wjd.v14.i8.1146]
URL: https://www.wjgnet.com/1948-9358/full/v14/i8/1146.htm
Number Citing Articles
1
Agnieszka Rybarczyk, Dorota Formanowicz, Piotr Formanowicz. Key Therapeutic Targets to Treat Hyperglycemia-Induced Atherosclerosis Analyzed Using a Petri Net-Based ModelMetabolites 2023; 13(12): 1191 doi: 10.3390/metabo13121191
2
Uwe Gröber, Hans-Peter Friedrichsen. Die Mitochondriopathie Diabetes mellitus – Intervention mit (Mikro-)Nährstoffen: Update 2023Zeitschrift für Orthomolekulare Medizin 2023; 21(04): 5 doi: 10.1055/a-2184-1916
3
Ayesha Fauzi, Ewen Se Thoe, Tang Yin Quan, Adeline Chia Yoke Yin. Insights from insulin resistance pathways: Therapeutic approaches against Alzheimer associated diabetes mellitusJournal of Diabetes and its Complications 2023; 37(11): 108629 doi: 10.1016/j.jdiacomp.2023.108629
4
Jose-Andres C. Portillo, Amelia Pfaff, Sarah Vos, Matthew Weng, Ram H. Nagaraj, Carlos S. Subauste. Advanced Glycation End Products Upregulate CD40 in Human Retinal Endothelial and Müller Cells: Relevance to Diabetic RetinopathyCells 2024; 13(5): 429 doi: 10.3390/cells13050429
5
Asis Bala. Regulatory role of peroxynitrite in advanced glycation end products mediated diabetic cardiovascular complicationsWorld Journal of Diabetes 2024; 15(3): 572-574 doi: 10.4239/wjd.v15.i3.572